KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Inventory Average (2016 - 2025)

Biogen has reported Inventory Average over the past 17 years, most recently at $2.2 billion for Q4 2025.

  • Quarterly results put Inventory Average at $2.2 billion for Q4 2025, down 11.2% from a year ago — trailing twelve months through Dec 2025 was $2.2 billion (down 11.2% YoY), and the annual figure for FY2025 was $2.3 billion, down 7.2%.
  • Inventory Average for Q4 2025 was $2.2 billion at Biogen, down from $2.2 billion in the prior quarter.
  • Over the last five years, Inventory Average for BIIB hit a ceiling of $2.8 billion in Q4 2023 and a floor of $1.1 billion in Q1 2021.
  • Median Inventory Average over the past 5 years was $1.8 billion (2022), compared with a mean of $1.8 billion.
  • Biggest five-year swings in Inventory Average: soared 102.61% in 2023 and later fell 11.2% in 2025.
  • Biogen's Inventory Average stood at $1.3 billion in 2021, then rose by 0.74% to $1.4 billion in 2022, then surged by 102.61% to $2.8 billion in 2023, then dropped by 10.53% to $2.5 billion in 2024, then fell by 11.2% to $2.2 billion in 2025.
  • The last three reported values for Inventory Average were $2.2 billion (Q4 2025), $2.2 billion (Q3 2025), and $2.3 billion (Q2 2025) per Business Quant data.